Doctors Note Logo

Published on: 9/23/2026

Who should get the RSV vaccine this season?

Yoshinori Abe

Reviewed by Yoshinori Abe, MD

Internal Medicine

RSV vaccination is recommended for all adults ages 75 and older, and for adults ages 50 to 74 who have risk factors such as chronic heart or lung disease, diabetes, obesity, weakened immune systems, or who live in nursing homes, while pregnant people are advised to get a single dose between 32 and 36 weeks of pregnancy during RSV season to protect newborns. The RSV vaccine is currently a one-time dose rather than an annual shot, so anyone already vaccinated in a previous season generally does not need another, and infants may instead be eligible for a protective monoclonal antibody. Timing, eligibility, and how RSV vaccination interacts with flu and COVID-19 shots involve important details, which you can review below.

If you are unsure whether your age, pregnancy status, or health conditions place you in a recommended group, or if you are already coughing, wheezing, or feverish and wondering whether RSV is to blame, a free, instant, online symptom check can help you sort out what is likely happening right now. It takes only a few minutes, is available any time without an appointment, and gives you a clearer sense of urgency and which questions to bring to your doctor or pharmacist next.

Last reviewed for medical accuracy: 09/23/2026

answer background

What brings you in today?

Can I treat this myselfDo I need to see a doctorWhere should I go for careI'm concerned about a symptomConcerned about a possible conditionMy symptoms are getting worseSeeking a second opinion

Not seeing your question? No worries.

Submit your own Question

Explanation

Who Should Get the RSV Vaccine This Season?

Respiratory syncytial virus (RSV) is a common respiratory infection that can cause serious illness in certain groups. Vaccination is now available to help protect those most at risk. Here’s what you need to know about who should get the RSV vaccine this season.

Why RSV Vaccination Matters

RSV typically causes cold-like symptoms in healthy children and adults. But it can lead to severe lung infections, such as bronchiolitis or pneumonia, especially in:

  • Infants and young children
  • Older adults
  • People with certain chronic health conditions

Getting vaccinated reduces the chances of severe illness, hospitalization and complications.

Who Should Get the RSV Vaccine

Adults 60 Years and Older

The Centers for Disease Control and Prevention (CDC) recommends RSV vaccination for all adults aged 60 and older. As we age, immune defenses weaken and the risk of severe RSV increases.

Benefits for this group:

  • Lower risk of hospitalization and severe respiratory disease
  • Decreased likelihood of complications, such as pneumonia
  • Reduced strain on family caregivers and health systems

Pregnant Individuals

Vaccination during pregnancy helps protect both the parent and their newborn. The American College of Obstetricians and Gynecologists (ACOG) and CDC recommend a single dose of RSV vaccine for pregnant people between 32 and 36 weeks of gestation.

Advantages include:

  • Transfer of protective antibodies across the placenta
  • Fewer RSV-related doctor visits and hospital stays for infants in their first six months
  • Peace of mind during the busiest season for respiratory viruses

Adults Aged 19–59 with High-Risk Conditions

While routine RSV vaccination is not yet recommended for all adults under 60, those with certain medical conditions may benefit. Talk with your health care provider if you have:

  • Chronic heart disease (for example, heart failure)
  • Chronic lung diseases (such as COPD or asthma)
  • Immunocompromising conditions (e.g., HIV, cancer treatment)
  • Neuromuscular disorders that impair swallowing or clearing secretions
  • Severe kidney disease or liver disorders
  • Diabetes with complications

Your doctor can help you weigh the benefits and decide if vaccination is appropriate.

Timing and Vaccine Options

  • Adults 60+: A single dose of RSV vaccine (two products are available; your provider will choose one).
  • Pregnant people: One dose between 32–36 weeks gestation.
  • High-risk adults 19–59: Follow your provider’s recommendation on timing.

Most vaccinations are given before or at the start of RSV season. In many regions, this is late fall through early spring, but timing can vary. Check local guidelines and talk to your health care provider.

Safety and Side Effects

RSV vaccines have undergone rigorous testing in clinical trials. Common side effects are generally mild and short-lived, such as:

  • Soreness, redness or swelling at the injection site
  • Low-grade fever
  • Muscle aches or fatigue
  • Headache

Serious reactions are rare. If you have concerns—especially a history of severe allergic reactions—discuss them with your provider before getting vaccinated.

How to Get Vaccinated

  1. Talk to Your Health Care Provider
    Explain your age, pregnancy status and any chronic health conditions. They’ll confirm your eligibility and recommend the right timing.
  2. Schedule Your Appointment
    RSV vaccines are available at primary care offices, obstetric clinics, pharmacies and some community health centers.
  3. Bring Your Insurance Card
    Most insurance plans, including Medicare Part B, cover RSV vaccination with no out-of-pocket cost.
  4. Follow Up if Needed
    RSV vaccination requires only one dose for eligible adults and pregnant people. No booster is currently recommended.

Monitoring Symptoms at Home

Even after vaccination, you may experience mild cold-like symptoms or fatigue. If you’re unsure whether you have RSV or another infection, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide you on next steps.

When to Seek Medical Care

Contact your health care provider or seek emergency care if you or a loved one experience any of the following:

  • Difficulty breathing or rapid breathing
  • Persistent high fever (especially in infants or older adults)
  • Blue-tinged lips or skin
  • Severe cough that interrupts normal activities
  • Signs of dehydration (dry mouth, little to no urine)
  • Confusion or sudden change in mental status

These could be signs of a serious RSV infection or another respiratory illness that needs prompt attention.

Talking With Your Doctor

This season, make RSV prevention part of your health plan. Speak to a doctor about:

  • Whether you or a family member should get the RSV vaccine
  • The best timing based on your health status and local RSV activity
  • Any concerns about side effects or interactions with other vaccines

Vaccination is one of the most effective ways to reduce RSV risk. Your doctor can provide personalized guidance and address any questions you have.

Stay informed, stay protected and talk to a health care professional about anything that could be life threatening or serious.

(References)

  • * Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, Swamy GK, Agrawal S, Ahmed K, August A, Baqui AH, Calvert A, Chen J, Cho I, Cotton MF, Cutland CL, Englund JA, Fix A, Gonik B, Hammitt L, Heath PT, de Jesus JN, Jones CE, Khalil A, Kimberlin DW, Libster R, Llapur CJ, Lucero M, Pérez Marc G, Marshall HS, Masenya MS, Martinón-Torres F, Meece JK, Nolan TM, Osman A, Perrett KP, Plested JS, Richmond PC, Snape MD, Shakib JH, Shinde V, Stoney T, Thomas DN, Tita AT, Varner MW, Vatish M, Vrbicky K, Wen J, Zaman K, Zar HJ, Glenn GM, Fries LF, Prepare Study Group. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 Jul 30;383(5):426-439. doi: 10.1056/NEJMoa1908380. PMID: 32726529; PMCID: PMC7299433.

  • * Simões EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC. Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy. N Engl J Med. 2022 Apr 28;386(17):1615-1626. doi: 10.1056/NEJMoa2106062. PMID: 35476650.

  • * Qiu X, Xu S, Lu Y, Luo Z, Yan Y, Wang C, Ji J. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53. doi: 10.1016/j.cytogfr.2022.10.001. Epub 2022 Oct 13. PMID: 36280532.

  • * Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A, MATISSE Study Group. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.

  • * Agac A, Kolbe SM, Ludlow M, Osterhaus ADME, Meineke R, Rimmelzwaan GF. Host Responses to Respiratory Syncytial Virus Infection. Viruses. 2023 Sep 26;15(10). doi: 10.3390/v15101999. Epub 2023 Sep 26. PMID: 37896776; PMCID: PMC10611157.

  • * Lichscheidt ED, Harboe ZB, Fischer TK, Larsen CS. Vaccines against respiratory syncytial virus. Ugeskr Laeger. 2024 Mar 11;186(11). doi: 10.61409/V12230800. PMID: 38533866.

  • * Pecenka C, Sparrow E, Feikin DR, Srikantiah P, Darko DM, Karikari-Boateng E, Baral R, Vizzotti C, Rearte A, Jalang'o R, Fleming JA, Martinón-Torres F, Karron RA. Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. Lancet. 2024 Sep 21;404(10458):1157-1170. doi: 10.1016/S0140-6736(24)01699-4. Epub 2024 Sep 9. PMID: 39265588.

  • * Terstappen J, Hak SF, Bhan A, Bogaert D, Bont LJ, Buchholz UJ, Clark AD, Cohen C, Dagan R, Feikin DR, Graham BS, Gupta A, Haldar P, Jalang'o R, Karron RA, Kragten L, Li Y, Löwensteyn YN, Munywoki PK, Njogu R, Osterhaus A, Pollard AJ, Nazario LR, Sande C, Satav AR, Srikantiah P, Stein RT, Thacker N, Thomas R, Bayona MT, Mazur NI. The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access. Lancet Infect Dis. 2024 Dec;24(12):e747-e761. doi: 10.1016/S1473-3099(24)00455-9. Epub 2024 Sep 23. PMID: 39326422; PMCID: PMC12311909.

  • * Simões EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, Llapur C, Baker J, Pérez Marc G, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Padilla MD, Richmond PC, Sarwar UN, Baber J, Koury K, Lino MM, Kalinina EV, Li W, Cooper D, Anderson AS, Swanson KA, Gurtman A, Munjal I, MATISSE (Maternal Immunization Study for Safety and Efficacy) Clinical Trial Group. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 1;145(2):157-167. doi: 10.1097/AOG.0000000000005816. Epub 2025 Jan 2. PMID: 39746212; PMCID: PMC11731064.

  • * Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.